No Data
No Data
Front market [stocks that have moved, stocks that have been created]
*TERRASKY <3915> 1670 Ka - I like the forecast for a significant increase in profit and the NTT DATA capital alliance. *BayCurrent <6532> 3453 - In addition to dividend increases and share buybacks, medium-term sales growth targets were also evaluated. *IDOM <7599> 1383 +300 This fiscal year is expected to increase significantly more than market expectations. *Sales deficit was revised upward to a drastic reduction with GUNOSY <6047> 796 +100 Game Eight as the driving force. *vector <6058> 1305 +158 consecutive for this term
JRC is ranked, operating profit forecast for the fiscal year ending 25/2 increased by 24.5%
JRC <6224> is in the ranking (as of 9:32). The price has been high since the beginning of the year. The operating profit forecast for the fiscal year ending 25/2 was announced at 1,582 billion yen, up 24.5% from the previous fiscal year. In addition to striving to acquire new projects centered on the food and pharmaceutical industry in the robot SI business, we will also focus on acquiring repeat projects from existing customers. Operating profit for the fiscal year ended 24/2 increased 1.5% to 1,270 billion yen. Top volume change rate [as of 4/15 09:32] (last 5 days average volume comparison) code
Is the downturn, weak US stocks, and the situation in the Middle East heavy, but is the lower price stiff
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to develop softly. In the US stock market on the 12th of last weekend, the Dow average depreciated by 475.84 dollars (-1.24%) to 37,983.24 dollars and continued to drop drastically for 5 days. Dull bank accounts, a sense of caution against the tense situation in the Middle East, and declining expectations for interest rate cuts from the Federal Reserve (Fed) weighed on stock prices and remained soft throughout the day. The decline widened towards the end of the game. Today's emerging markets are likely to be dominated by sales. US stocks last weekend
Astellas Pharmaceuticals, 24/3 revised downward operating profit 13 billion yen ← 83 billion yen
Astellas Pharmaceuticals <4503> announced revisions to its earnings forecast for the fiscal year ending 2024/3. Operating profit was revised downward from 83 billion yen to 13 billion yen. As a result of reviewing the asset value of the gene therapy program AT808, which is undergoing research and development for Friedreich ataxia patients, impairment losses of approximately 40 billion yen of intangible assets related to AT808 will be recorded as other expenses. [Positive Evaluation] <8233>Takashimaya Full Year | <6432>Takeuchi Production
Bic Camera, Money Forward, Ryohin Keikaku, Takashimaya (12 days)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------4/12 (Fri) <1401>mbs <1407>West HD<1418>Interlife <1434>JESCOHD<2153>Ejay HD <2168>Pasona G<2305>Studio Alice <2379>dip
Tama Home, Lawson, Hisamitsuyaku, Fast Lite (11 days)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------4/11 (Thu) <137A>Cocolive <1419>Tama Home <2341>Part-time job in Thailand <2459>Aung <2651>Lawson <2742>Harrows<2791>Daikokuten <2882>Eat and
No Data